Patents by Inventor Dimitry Serge Antoine Nuyten

Dimitry Serge Antoine Nuyten has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PD-L1 ANTAGONIST COMBINATION TREATMENTS
    Publication number: 20210069326
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent, and the use of the combination therapies for the treatment of cancer.
    Type: Application
    Filed: November 19, 2020
    Publication date: March 11, 2021
    Inventors: Glen Ian ANDREWS, Shihao CHEN, Alessandra DI PIETRO, David FONTANA, Zelanna GOLDBERG, Chia-Yang LIN, Hua LONG, Marcella MARTIGNONI, Dimitry Serge Antoine NUYTEN, Aron David THALL, Adrian WOOLFSON
  • PD-L1 antagonist combination treatments
    Patent number: 10869924
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent, and the use of the combination therapies for the treatment of cancer.
    Type: Grant
    Filed: June 15, 2016
    Date of Patent: December 22, 2020
    Assignees: MERCK PATENT GMBH, PFIZER INC.
    Inventors: Glen Ian Andrews, Shihao Chen, Alessandra Di Pietro, David Fontana, Zelanna Goldberg, Chia-Yang Lin, Hua Long, Marcella Martignoni, Dimitry Serge Antoine Nuyten, Aron David Thall, Adrian Woolfson
  • Combination of a PARP Inhibitor and a PD-1 Axis Binding Antagonist
    Publication number: 20200254091
    Abstract: This invention relates to a method of treating cancer by administering a PARP inhibitor in combination with a PD-1 axis binding antagonist to a patient in need thereof.
    Type: Application
    Filed: October 10, 2018
    Publication date: August 13, 2020
    Inventors: John Andrew Blake-Haskins, Christoffel Hendrik Boshoff, Rossano Cesari, Dimitry Serge Antoine Nuyten, Ross Anthony Stewart, Fabian Zohren
  • PD-L1 Antagonist Combination Treatments
    Publication number: 20180169232
    Abstract: The present disclosure describes combination therapies comprising an antagonist of Programmed Death Ligand 1 receptor (PD-L1) and another therapeutic agent, and the use of the combination therapies for the treatment of cancer.
    Type: Application
    Filed: June 15, 2016
    Publication date: June 21, 2018
    Applicants: MERCK PATENT GMBH, PFIZER INC.
    Inventors: Glen Ian ANDREWS, Shihao CHEN, Alessandra DI PIETRO, David FONTANA, Zelanna GOLDBERG, Chia-Yang LIN, Hua LONG, Marcella MARTIGNONI, Dimitry Serge Antoine NUYTEN, Aron David THALL, Adrian WOOLFSON
  • Prediction of Local Recurrence of Breast Cancer
    Publication number: 20090220956
    Abstract: The invention relates to the field of medicine, in particular to cancer, more specifically breast cancer, most specifically to a method to predict the local recurrence of breast cancer after breast conserving therapy. It has been demonstrated that a classification on basis of the similarity of the gene expression profile to the gene expression profile of (serum) activated fibroblasts is able to distinguish significantly in risk of local recurrence in breast cancer patients.
    Type: Application
    Filed: October 25, 2006
    Publication date: September 3, 2009
    Inventor: Dimitry Serge Antoine Nuyten